Jayanta Kumar MANDAL
39Patents
2h-index
19Co-inventors
50Inventor score
Filing activity: Mar 29, 2010 → Nov 12, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11253474B1 | Pharmaceutical solution of amlodipine | Human Necessities | 3 | Active |
| US11337979B2 | Liquid oral formulations for sildenafil | Human Necessities | 3 | Active |
| US11931455B2 | Pharmaceutical suspension for oral dosage | Human Necessities | 2 | Active |
| US11918684B2 | Pharmaceutical composition of oral suspension of immunosuppressive agents | Human Necessities | 2 | Active |
| US11464778B2 | Liquid oral formulations for sildenafil | Human Necessities | 2 | Active |
| US10314880B2 | Composition comprising bortezomib | Human Necessities | 1 | Active |
| US11458095B2 | Pharmaceutical solution of amlodipine | Human Necessities | 1 | Active |
| US12005141B2 | Pharmaceutical solution of amlodipine | Human Necessities | 1 | Active |
| US8058076B2 | In-vitro method for testing bioequivalence of iron-sucrose formulation | Emerging Cross-Sectional Technologies | 1 | Active |
| US11868934B1 | Virtual fulfillment centers for item delivery | Physics | 1 | Active |
| US11723866B2 | Pharmaceutical solution of amlodipine | Human Necessities | 1 | Active |
| US11975006B2 | Liquid oral formulations for tadalafil | Human Necessities | 0 | Active |
| US11759468B2 | Liquid oral formulations for sildenafil | Human Necessities | 0 | Active |
| US12097284B2 | Mycophenolate oral suspension | Human Necessities | 0 | Active |
| US12303504B2 | Non-aqueous chemotherapeutic suspensions for oral dosage | Human Necessities | 0 | Active |
| US12226526B2 | Mycophenolate oral suspension | Human Necessities | 0 | Active |
| US12186321B2 | Liquid oral formulations for sildenafil | Human Necessities | 0 | Active |
| US12016857B2 | Stable liquid vigabatrin pharmaceutical composition for oral dosage | Human Necessities | 0 | Active |
| US12194143B2 | Mycophenolate oral suspension | Human Necessities | 0 | Active |
| US12083222B2 | Chemotherapeutic pharmaceutical suspension for oral dosage | Human Necessities | 0 | Active |
| US12168069B2 | Aqueous suspension suitable for oral administration | Human Necessities | 0 | Active |
| US12097285B2 | Mycophenolate oral suspension | Human Necessities | 0 | Active |
| US12186322B2 | Liquid oral formulations for tadalafil | Human Necessities | 0 | Active |
| US11147810B2 | Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agents | Human Necessities | 0 | Active |
| US11382917B2 | Liquid oral formulations for tadalafil | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.